Blincyto's label has gradually been extended since 2014, and in December the MHRA approved it as the first immunotherapy for ...
Shares of Amgen Inc. AMGN advanced 1.24% to $297.93 Thursday, on what proved to be an all-around dismal trading session for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback